Günter Breithardt
Breithardt, Günter, 1944-
Breithardt, Günter
Breithardt, Günter, 19..-....
Breithardt, Günther (Günter), Cardiology
VIAF ID: 19908828 (Personal)
Permalink: http://viaf.org/viaf/19908828
Preferred Forms
- 200 _ | ‡a Breithardt ‡b Günter
- 100 1 _ ‡a Breithardt, Günter
-
- 100 1 _ ‡a Breithardt, Günter ‡d 1944-
- 100 1 _ ‡a Breithardt, Günter, ‡d 19..-....
-
-
- 100 1 _ ‡a Breithardt, Günter
-
-
-
- 100 1 _ ‡a Breithardt, Günter ‡d 1944-
-
- 100 0 _ ‡a Günter Breithardt
4xx's: Alternate Name Forms (16)
5xx's: Related Names (1)
- 551 _ _ ‡a Münster (Westf)
Works
Title | Sources |
---|---|
Antiarrhythmic drugs : mechanisms of antiarrhythmic and proarrhythmic actions | |
Antiarrhythmic therapy : a pathophysiologic approach | |
Automatic implantable cardioverter defibrilator therapy : lessons from the 1980S, expectations for the 1990S : an international symposium, October 17-19, 1991, Brussels | |
Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry) | |
Cardiac mapping | |
Erwachsene mit angeborenen Herzfehlern (EMAH) : S2-Leitlinie der DGK, DGPK und DGTHG zur Diagnostik und Therapie in Klinik und Praxis | |
Genome-wide association study suggests impact of chromosome 10 rs139401390 on kidney function in patients with coronary artery disease | |
Gutartiges Herzjagen | |
Herz und Kreislauf. | |
Herzrhythmusstörungen | |
Moderne Herzrhythmustherapie 97 Tabellen | |
Myocardial repolarization from gene to bedside | |
N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure. | |
Neue Aspekte in der medikamentösen Behandlung von Tachyarrhythmien d. Bedeutung von Amiodaron | |
New aspects in the medical treatment of tachyarrhythmias role of amiodarone | |
Nonpharmacological therapy of tachyarrhythmias, 1987: | |
One-year follow-up of the Polish subset of the RecordAF registry of patients with newly diagnosed atrial fibrillation | |
Plötzlicher Herztod der gefährdete Patient | |
The predictive value of echocardiographic parameters associated with left ventricular diastolic dysfunction on short- and long-term outcomes of catheter ablation of atrial fibrillation | |
Prevalence of supraventricular tachyarrhythmias in a cohort of 115 patients with Brugada syndrome | |
Primary prevention of sudden cardiac death | |
Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes | |
[The procedure of echocardiographic tests] | |
Prognostic value of a restrictive mitral filling pattern in patients with systolic heart failure and an implantable cardioverter-defibrillator | |
Prognostic value of different laboratory measures of renal function for long-term mortality after contrast media-associated renal impairment | |
Progress in cardiology dedicated to Professor Franz Loogen on the occasion of his 80th birthday | |
Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). | |
Recurrent syncope triggered by inappropriate sinus tachycardia | |
Reduced repolarization reserve due to anthracycline therapy facilitates torsade de pointes induced by IKr blockers | |
Reentrant circuits in the canine atrioventricular node during atrial and ventricular echoes: electrophysiological and histological correlation | |
Regional, age-dependent, and genotype-dependent differences in ventricular action potential duration and activation time in 410 Langendorff-perfused mouse hearts | |
The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management | |
Relation of functional echocardiographic parameters to infarct scar transmurality by magnetic resonance imaging. | |
Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index | |
Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial | |
Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents. | |
Risk predictors for adverse outcomes after percutaneous coronary interventions and their related costs | |
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation | |
Role of deformation imaging in diagnosing myocardial ischemia | |
Safe performance of magnetic resonance imaging on a patient with an ICD. | |
Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial | |
Sex differences in absolute myocardial perfusion. Non-invasive H2(15)O-PET in young healthy adults. | |
Short QT interval and short QT syndromes | |
Should all patients with heart failure and left ventricular dysfunction receive combined CRT-ICD therapy? | |
Significant gender-related differences in radiofrequency catheter ablation therapy. | |
Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). | |
Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease | |
Soluble Flt-1 links microvascular disease with heart failure in CKD. | |
Spontaneous Brugada electrocardiogram patterns are rare in the German general population: results from the KORA study | |
Stress and high heart rate provoke ventricular tachycardia in mice expressing triadin | |
Sudden infant death syndrome and long QT syndrome: an epidemiological and genetic study. | |
Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease | |
A symposium : new frontiers in the electrical management of cardiac disorders | |
Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial | |
Thema: Fortschritte und Kontroversen in der Kardiologie Update 2000 ; vom 21. bis 23. September 2000 in Münster | |
Therapeutic options and heart failure survival score predictability in an academic heart failure center: an analysis of 120 consecutive patients during a 1-year period | |
Time dependent changes of arterial distensibility induced by cholesterol and balloon injury in rabbits: an in vivo intravascular ultrasound study | |
Tissue Doppler imaging in patients with moderate to severe aortic valve stenosis: clinical usefulness and diagnostic accuracy. | |
[Tissue Doppler imaging of the fetal heart--a new parametric ultrasound technique in prenatal medicine] | |
Too weak to withstand the strain: another piece in the CRT puzzle. | |
Torsade de pointes oder die andere Ursache des plötzlichen Herztodes | |
Transgenic model of smooth muscle cell cycle reentry: expression pattern of the collageneous matrix. | |
Transition in Patients with Congenital Heart Disease in Germany: Results of a Nationwide Patient Survey | |
Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3 | |
Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atr | |
Treatment with novel oral anticoagulants in a real-world cohort of patients undergoing cardiac rhythm device implantations. | |
Trends in cardiovascular risk factors among patients with coronary heart disease: results from the EUROASPIRE I, II, and III surveys in the Münster region | |
Update of the guidelines on sudden cardiac death of the European Society of Cardiology | |
Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial | |
Usefulness of tissue Doppler imaging for estimation of left ventricular filling pressures in patients with systolic and diastolic heart failure | |
Validation of the peak to mean pressure decrease ratio as a new method of assessing aortic stenosis using the Gorlin formula and the cardiovascular magnetic resonance-based hybrid method. | |
Vascular injury response in mice is dependent on genetic background | |
Vascular ligation response is independent of p107: stressing the role of the related p130. | |
Vasoactive peptides during long-term follow-up of patients after cardiac transplantation. | |
Venice Chart International Consensus document on ventricular tachycardia/ventricular fibrillation ablation. | |
Ventricular arrhythmias, increased cardiac calmodulin kinase II expression, and altered repolarization kinetics in ANP receptor deficient mice | |
Ventrikuläre Spätpotentiale nach Myokardinfarkt Abschlussbericht zur prospektiven Beobachtungsstudie "Prognostische Bedeutung ventrikulärer Spätpotentiale nach Myokardinfarkt" | |
Vorhofflimmern aktuelle Aspekte = Atrial fibrillation : current aspects | |
Vorhofflimmern - eine Standortbestimmung - Vorkommen, Mechanismen und klinische Präsentation | |
“Zooming in” to new horizons: Conduction abnormalities and other research perspectives in atrial fibrillation |